Information Provided By:
Fly News Breaks for August 1, 2018
INCY, CYTK, BRX, HRZN, SHOP
Aug 1, 2018 | 10:25 EDT
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Shopify (SHOP) downgraded to Neutral from Overweight at Piper Jaffray with analyst Michael Olson saying that Shopify's Q2 was "good, but not good enough" with monthly recurring revenue below investor expectations with a deceleration from 57% to 49% year-over-year growth between Q1 and Q2. 2. Horizon Technology (HRZN) downgraded to Sell from Neutral at Compass Point. 3. Brixmor (BRX) downgraded to Hold from Buy at Sandler O'Neill. 4. Cytokinetics (CYTK) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Matthew Harrison saying management attributed the delay to the availability and uptake of Radicava,a new treatment for ALS. 5. Incyte (INCY) downgraded to Market Perform from Outperform at JMP Securities with analyst Liisa Bayko saying Q2 results "did not disappoint," but she no longer thinks her prior assumption of 10% annual price increases on Jakafi is likely given the political environment and recent California transparency law. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
News For SHOP;HRZN;BRX;CYTK;INCY From the Last 2 Days
There are no results for your query SHOP;HRZN;BRX;CYTK;INCY